Product Program year 2024 Source: CMS Open Payments

Merlin@Home

Device Cardiac Rhythm Management

PDI 05414734504799

Open in the dashboard

General payments

$480,186

5,453 payments

Research payments

$0

0 payments

Through program year 2024, $480,186 in general payments and $0 in research payments were reported against Merlin@Home (Cardiac Rhythm Management).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2024 General $97,155 1,469
2023 General $153,366 1,639
2022 General $229,665 2,345

Breakdown

Who paid General payments · program years 2022–2024
  1. Abbott Laboratories $480,186 5,453 payments
Top recipients General payments · program year 2024
  1. Leslie Saxon Clinical Cardiac Electrophysiology · Los Angeles, CA $37,870 39% · 27 payments
  2. Adam Landman Emergency Medicine · Boston, MA $6,010 6% · 16 payments
  3. Benjamin D Souza Clinical Cardiac Electrophysiology · Cherry Hill, NJ $2,138 2% · 2 payments
  4. Mohit Turagam Clinical Cardiac Electrophysiology · New York, NY $2,020 2% · 4 payments
  5. Daniel Marks Clinical Cardiac Electrophysiology · Joliet, IL $1,954 2% · 5 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2024.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2024
  1. Clinical Cardiac Electrophysiology Internal Medicine $57,109 59% · 123 practitioners
  2. Cardiovascular Disease Internal Medicine $9,898 10% · 206 practitioners
  3. Emergency Medicine $6,705 7% · 7 practitioners
  4. Interventional Cardiology Internal Medicine $4,910 5% · 99 practitioners
  5. Nurse Practitioner, Family Nurse Practitioner $2,852 3% · 68 practitioners

The top 5 of 52 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2024
  1. California $41,909 43% · 76 recipients
  2. Texas $11,590 12% · 177 recipients
  3. Michigan $6,447 7% · 23 recipients
  4. Massachusetts $6,198 6% · 5 recipients
  5. Puerto Rico $4,691 5% · 46 recipients

The top 5 of 47 states; each share is of general payments naming this product in 2024 where a state was reported.

The top 25 states, free in the app

5,453 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record